David Novack - Feb 10, 2025 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
President & COO
Signature
/s/ David Novack
Stock symbol
DVAX
Transactions as of
Feb 10, 2025
Transactions value $
-$59,638
Form type
4
Date filed
2/12/2025, 05:37 PM
Previous filing
Feb 20, 2024
Next filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Options Exercise +8.83K +37.84% 32.2K Feb 10, 2025 Direct F1, F2
transaction DVAX Common Stock Tax liability -$59.6K -4.52K -14.04% $13.20 27.7K Feb 10, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Restricted Stock Unit Options Exercise -8.83K -100% 0 Feb 10, 2025 Common Stock 8.83K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
F2 Includes 1,251 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 15, 2024.
F3 Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.